599 related articles for article (PubMed ID: 17375639)
1. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
2. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
6. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
8. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
[TBL] [Abstract][Full Text] [Related]
9. Transtympanic steroids for Ménière's disease.
Herraiz C; Plaza G; Aparicio JM; Gallego I; Marcos S; Ruiz C
Otol Neurotol; 2010 Jan; 31(1):162-7. PubMed ID: 19924013
[TBL] [Abstract][Full Text] [Related]
10. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
11. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin for Menière's disease: a meta-analysis.
Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
[TBL] [Abstract][Full Text] [Related]
14. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
Suryanarayanan R; Srinivasan VR; O'Sullivan G
J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
[TBL] [Abstract][Full Text] [Related]
15. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
[TBL] [Abstract][Full Text] [Related]
17. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
Smith WK; Sandooram D; Prinsley PR
J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
[TBL] [Abstract][Full Text] [Related]
20. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
Crane BT; Minor LB; Della Santina CC; Carey JP
Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
